Correlation Between Maoming Petro and Cabio Biotech
Specify exactly 2 symbols:
By analyzing existing cross correlation between Maoming Petro Chemical Shihua and Cabio Biotech Wuhan, you can compare the effects of market volatilities on Maoming Petro and Cabio Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maoming Petro with a short position of Cabio Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maoming Petro and Cabio Biotech.
Diversification Opportunities for Maoming Petro and Cabio Biotech
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Maoming and Cabio is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Maoming Petro Chemical Shihua and Cabio Biotech Wuhan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabio Biotech Wuhan and Maoming Petro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maoming Petro Chemical Shihua are associated (or correlated) with Cabio Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabio Biotech Wuhan has no effect on the direction of Maoming Petro i.e., Maoming Petro and Cabio Biotech go up and down completely randomly.
Pair Corralation between Maoming Petro and Cabio Biotech
Assuming the 90 days trading horizon Maoming Petro Chemical Shihua is expected to under-perform the Cabio Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Maoming Petro Chemical Shihua is 2.54 times less risky than Cabio Biotech. The stock trades about -0.06 of its potential returns per unit of risk. The Cabio Biotech Wuhan is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 1,997 in Cabio Biotech Wuhan on December 24, 2024 and sell it today you would earn a total of 584.00 from holding Cabio Biotech Wuhan or generate 29.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Maoming Petro Chemical Shihua vs. Cabio Biotech Wuhan
Performance |
Timeline |
Maoming Petro Chemical |
Cabio Biotech Wuhan |
Maoming Petro and Cabio Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Maoming Petro and Cabio Biotech
The main advantage of trading using opposite Maoming Petro and Cabio Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maoming Petro position performs unexpectedly, Cabio Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabio Biotech will offset losses from the drop in Cabio Biotech's long position.Maoming Petro vs. Jilin Jlu Communication | Maoming Petro vs. Fujian Nebula Electronics | Maoming Petro vs. Success Electronics | Maoming Petro vs. Dr Peng Telecom |
Cabio Biotech vs. Xilinmen Furniture Co | Cabio Biotech vs. Shandong Homey Aquatic | Cabio Biotech vs. Eyebright Medical Technology | Cabio Biotech vs. China World Trade |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |